Durvalumab-Induced Hyperprogressive Disease in Nonmetastatic Lung Cancer.

Autor: Khreis TJ; 1 Albany Medical College, Albany, NY., Azar IH; 1 Albany Medical College, Albany, NY., Patel R; 2 Albany Stratton VA Medical Center, Albany, NY., Mehdi SA; 2 Albany Stratton VA Medical Center, Albany, NY.
Jazyk: angličtina
Zdroj: Journal of oncology practice [J Oncol Pract] 2019 Apr; Vol. 15 (4), pp. 217-219. Date of Electronic Publication: 2019 Mar 18.
DOI: 10.1200/JOP.18.00739
Databáze: MEDLINE